Literature DB >> 2940213

The comparative in-vitro activity of pefloxacin.

A King, I Phillips.   

Abstract

The in-vitro antibacterial activities of pefloxacin, other 4-quinolones and representative beta-lactams and aminoglycosides were assessed by determination of minimum inhibitory concentrations (MICs). Pefloxacin (MICs mostly 0.03-2 mg/l) was highly active against Enterobacteriaceae. Gentamicin had slightly lower activity, and ceftazidime and norfloxacin similar activities to pefloxacin whereas ciprofloxacin was more active. Pefloxacin (MICs 0.03-2 mg/l) was active against Acinetobacter but again ciprofloxacin was more active. Aeromonas was highly susceptible to pefloxacin and norfloxacin (MICs 0.008-0.03 mg/l) as well as to ciprofloxacin (MICs 0.001-0.008 mg/l). Pefloxacin (MICs 1-8 mg/l) had similar activities to ceftazidime and gentamicin against Pseudomonas aeruginosa but tobramycin (MICs 0.25-32 mg/l), norfloxacin (MICs 0.25-4 mg/l) and ciprofloxacin (MICs 0.06-1 mg/l) were generally more active. Haemophilus influenzae was susceptible to pefloxacin (MICs 0.008-0.06 mg/l) and to norfloxacin and ciprofloxacin, all of which were more active than ampicillin or ceftazidime. Gardnerella vaginalis was not very susceptible to pefloxacin (MICs 2-8 mg/l), the other 4-quinolones or gentamicin but ampicillin and ceftazidime were highly active. Neisseria gonorrhoeae was very susceptible to pefloxacin and norfloxacin (MICs 0.016-0.12 mg/l) and ciprofloxacin (MICs 0.002-0.008 mg/l). The activity of pefloxacin (MICs 0.25-1 mg/l) was similar to that of ciprofloxacin (MICs 0.12-2 mg/l) but greater than that of norfloxacin (MICs 0.5-4 mg/l) against Staphylococcus aureus. Vancomycin (MICs 1-2 mg/l) had similar activity in vitro but whilst gentamicin was highly active against some isolates, others were resistant. Pefloxacin (MICs mostly 4-32 mg/l) and the other 4-quinolones had lower activity against streptococci (including alpha-, beta-, and non-haemolytic strains, enterococci and pneumococci) than against staphylococci. Benzylpenicillin (or ampicillin in the case of enterococci) were usually more active than any of the 4-quinolones. Bacteroides species, both of the fragilis and melaninogenicus/oralis groups were generally moderately resistant to pefloxacin (MICs 2-32 mg/l) and norfloxacin though ciprofloxacin was more active. Whilst the activity of pefloxacin and the other 4-quinolones was generally somewhat higher against the other anaerobes, ampicillin generally had greater activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940213     DOI: 10.1093/jac/17.suppl_b.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Penetration of pefloxacin into maxillary sinus cavity and nasal secretions.

Authors:  G Petrikkos; P Goumas; E Moschovakis; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections.

Authors:  C Timmerman; I Hoepelman; J de Hond; T Boon; L Schreinemachers; H Mensink; J Verhoef
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

3.  Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis.

Authors:  J L Schmit; L Hary; P Bou; H Renaud; P F Westeel; M Andrejak; A Fournier
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis.

Authors:  B Jacoberger; G Ubeaud; G Freys; T Pottecher; L Jung; J C Koffel
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

5.  Penetration of pefloxacin into bronchial secretions.

Authors:  G Bonmarchand; J J Grès; G Lerebours; P Massari; J J Mayoux; A Montay; J Leroy
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

6.  Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.

Authors:  S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

7.  Intraperitoneal penetration of pefloxacin.

Authors:  J M Webberly; I Donovan; R Wise; J Ashby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 8.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.

Authors:  M L Patchen; I Brook; T B Elliott; W E Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).

Authors:  G Verschraegen; G Claeys; A M Van den Abeele
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.